Optic Neuritis After SARS-CoV-2 Vaccination.
Journal
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
ISSN: 1536-5166
Titre abrégé: J Neuroophthalmol
Pays: United States
ID NLM: 9431308
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
entrez:
15
2
2023
pubmed:
16
2
2023
medline:
17
2
2023
Statut:
ppublish
Résumé
To describe recent cases of optic neuritis in patients who received a vaccine for COVID-19. Retrospective case series of patients diagnosed with optic neuritis after a recent COVID-19 vaccination with BNT162b2 (Pfizer-BioNTech), in one university-affiliated tertiary hospital, from January 2021 to June 2021. Data were obtained from medical charts. We describe 7 patients who developed optic neuritis after immunization with the BNT162b2 vaccine. A causal relationship cannot be deduced, and the importance of COVID-19 vaccination is not challenged. However, the authors encourage a prospective monitoring and reporting system for all patients receiving COVID-19 vaccines, to further assess the spectrum of adverse events in large databases.
Sections du résumé
BACKGROUND
To describe recent cases of optic neuritis in patients who received a vaccine for COVID-19.
METHODS
Retrospective case series of patients diagnosed with optic neuritis after a recent COVID-19 vaccination with BNT162b2 (Pfizer-BioNTech), in one university-affiliated tertiary hospital, from January 2021 to June 2021. Data were obtained from medical charts.
RESULTS
We describe 7 patients who developed optic neuritis after immunization with the BNT162b2 vaccine.
CONCLUSIONS
A causal relationship cannot be deduced, and the importance of COVID-19 vaccination is not challenged. However, the authors encourage a prospective monitoring and reporting system for all patients receiving COVID-19 vaccines, to further assess the spectrum of adverse events in large databases.
Identifiants
pubmed: 36790061
doi: 10.1097/WNO.0000000000001811
pii: 00041327-202303000-00004
pmc: PMC9924740
doi:
Substances chimiques
BNT162 Vaccine
0
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
29-33Informations de copyright
Copyright © 2022 by North American Neuro-Ophthalmology Society.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Anon. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19, 2020. Available at: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 . Accessed August 19, 2022.
Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee Meeting FDA Briefing Document. Pfizer-BioNTech COVID-19 Vaccine, 2020. Available at: https://www.fda.gov/media/144245/download . Accessed July 15, 2022.
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Perez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, Kalina WV, Cooper D, Frenck RW, Hammitt LL, Tureci O, Nell H, Schaefer A, Unal S, Tresnan DB, Mather S, Dormitzer PR, Sahin U, Jansen KU, Gruber WC. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615.
Waheed S, Bayas A, Hindi F, Rizvi Z, Espinosa PS. Neurological Complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine. Cureus. 2021;13:e13426.
Mevorach D, Anis E, Cedar N, Bromberg M, Haas EJ, Nadir E, Olsha-Castell S, Arad D, Hasin T, Levi N, Asleh R, Amir O, Meir K, Cohen D, Dichtiar R, Novick D, Hershkovitz Y, Dagan R, Leitersdorf I, Ben-Ami R, Miskin I, Saliba W, Muhsen K, Levi Y, Green MS, Keinan-Boker L, Alroy-Preis S. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N Engl J Med. 2021;385:2140–2149.
Shemer A, Pras E, Hecht I. Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination. Isr Med Assoc J. 2021;23:143–144.
Tomkins-Netzer O, Sar S, Barnett-Griness O, Friedman B, Shyriaieva H, Saliba W. Association between vaccination with the BNT162b2 mRNA coronavirus disease 2019 vaccine and noninfectious uveitis: a Population-Based Study. Ophthalmology. 2022;129:1087–1095.
Bennett JL. Optic neuritis. Continuum. 2019;25:1236–1264.
Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014;13:215–224.
Pirani V, Pelliccioni P, Carpenè MJ, Nicolai M, Barbotti F, Franceschi A, Mariotti C. Optic neuritis following COVID-19 vaccination: do autoimmune diseases play a role? Eur J Ophthalmol. 2022:11206721221118736. Online ahead of print.
Tugizova M, Siegel DT, Huang S, Su E, Subramanian PS, Beres S, Vora N. Case series: atypical optic neuritis after COVID-19 vaccination. J Neuroophthalmol. 2022. doi: 10.1097/WNO.0000000000001519. Online ahead of print.
doi: 10.1097/WNO.0000000000001519
Roy M, Chandra A, Roy S, Shrotriya C. Optic neuritis following COVID-19 vaccination: coincidence or side-effect?—a case series. Indian J Ophthalmol. 2022;70:679–683.
García-Estrada C, Gómez-Figueroa E, Alban L, Arias-Cárdenas A. Optic neuritis after COVID-19 vaccine application. Clin Exp Neuroimmunol. 2022;13:72–74.
Leber HM, Sant'Ana L, Konichi da Silva NR, Raio MC, Mazzeo TJMM, Endo CM, Nascimento H, de Souza CE. Acute thyroiditis and bilateral optic neuritis following SARS-CoV-2 vaccination with CoronaVac: a case report. Ocul Immunol Inflamm. 2021;29:1200–1206.
Donaldson LC, Margolin EA. Myelin oligodendrocyte glycoprotein antibody–mediated optic neuritis following COVID-19 vaccination. J Neuroophthalmol. 2022 Online ahead of print.
Morena J, Gyang TV. Myelin oligodendrocyte glycoprotein antibody-associated disease and transverse myelitis probably associated with SARS-CoV-2 mRNA vaccines: two case reports. Neurohospitalist. 2022;12:536–540.
Netravathi M, Dhamija K, Gupta M, Tamborska A, Nalini A, Holla V, Nitish L, Menon D, Pal P, Seena V, Yadav R, Ravindranadh M, Faheem A, Saini J, Mahadevan A, Solomon T, Singh B. COVID-19 vaccine associated demyelination & its association with MOG antibody. Mult Scler Relat Disord. 2022;60:103739.
Jarius S, Bieber N, Haas J, Wildemann B. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature. J Neurol. 2022;269:5198–5212.
Shoenfeld Y, Roszkiewicz J. Vaccines and optic neuritis: consequence or coincidence? Immun Res. 2021;17:7467.
Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480.
Falcão-Gonçalves AB, Bichuetti DB, de Oliveira EML. Recurrent optic neuritis as the initial symptom in demyelinating diseases. J Clin Neurol. 2018;14:351.